The IPOX® Week, February 24, 2020

  • Spreads move in favor of IPOX during U.S. option expiration week: IPOX Indexes record big relative performance jump.
  • Nordic the place to be as IPOX Nordic jumps +4.49%.
  • IPO Deal-flow Review & Outlook: Thailand’s retail giant Central Retail launched the country’s biggest-ever IPO. Light deal flow expected towards month end.

Spreads move in favor of IPOX during U.S. option expiration week: IPOX Indexes record big relative performance jump. The IPOX Indexes topped the weekly global equity indexes performance rankings last week, less affected than the benchmarks by the increasing COVID-19 containment fears rallying U.S. bonds and spiking U.S. equity risk (VIX: +24.85%). In the U.S., e.g., the FANG-free, broad-based IPOX 100 U.S. (ETF: FPX) shed just -0.13% to +7.71% YTD, extending the YTD lead vs. the S&P 500 (SPX)- benchmark for U.S. equities – by +113 bps. to +440 bps. YTD. Big

IPOX® 100 U.S. ETF (ticker: FPX) Investing since 04/2006:

relative gains extended to the IPOX International (ETF: FPXI) and IPOX Europe (ETF: FPXE). We also note a fresh weekly all-time high in the IPOX Nordic (IPND) which surged +4.49% to +14.99% YTD, pushed higher by a big rally in portfolio holdings application software maker Sinch AB (SINCH SS: +28.44%), real estate developer Samhallsbyggnadsbolaget i Norden AB (SBBB SS: +20.80%) and global toys and games maker Embracer Group AB (EMBRACB SS: +16.42%). Portfolio returns were more evenly distributed in the IPOX 100 U.S. (ETF: FPX). Here, 67/100 holdings closed last week in negative territory, with the average (median) equally-weighted constituent dropping by -0.97% (-1.22%), significantly more than when compared to the applied market-cap weighted IPOX 100 U.S. (ETF: FPX). Amid the big declines in mega-cap U.S. technology stocks (NDX: -1.84%), the sharp drop in application software maker Appian (APPN US: -18.67%), biotech Apellis Pharma (APLS US: -12.17%) and Chicago-based consumer staple Conagra (CAG US: -9.48%) after reporting weak earnings were almost offset by the surge in IPOX 100 U.S. (ETF: FPX) portfolio holdings car vending machine operator Carvana (CVNA US: +24.23%), electric car maker IPO M&A’s Tesla (TSLA US: +12.62%) and grocery retailer Kroger (KR US: +7.37%) which got a boost from news that Warren Buffetts Berkshire Hathaway (BRK/B US: +1.04%) initiated a stake in the firm during Q4/2019.

Select IPOX® Indexes Price Returns (%) Last Week 2019 2020 YTD
IPOX® Indexes: Global/International
IPOX® Global (IPGL50) (USD) 0.75 27.93 9.11
IPOX® International (IPXI)* (USD) 0.26 31.37 6.55
IPOX® Indexes: United States
IPOX® 100 U.S. (IPXO)* (USD) -0.13 29.60 7.71
IPOX® Indexes: Europe/Nordic
IPOX® 30 Europe (IXTE) (EUR) 0.99 34.55 10.54
IPOX® Nordic (IPND) 4.49 38.52 14.99
IPOX® 100 Europe (IPOE)* (USD) 0.69 30.97 3.67
IPOX® Indexes: Asia-Pacific/China
IPOX® Asia-Pacific (IPTA) (USD) -1.04 4.41 1.65
IPOX® China (CNI) (USD) 0.32 26.31 6.58
IPOX® Japan (IPJP)** (JPY) -2.34 7.91 -2.57

* Basis for ETFs: FPX US, FPX LN, FPXE US, FPXU FP, FPXI US, TCIP110 IT and CME-traded e-mini IPOX® 100 U.S. Futures (IPOH0). Source: Bloomberg L.P.

IPOX ETFs 2020 YTD Returns: IPOX 100 U.S. (ETF: FPX): +7.97%; IPOX International (ETF: FPXI): +5.64%; IPOX 100 Europe (ETF: FPXE): +3.37%.

IPO Deal-flow Review and Outlook: Thailand’s retail giant Central Retail launched the country’s biggest-ever IPO. Light deal flow expected towards month end. 5 firms commenced trading across the global regions last week with the average (median) equally-weighted deal adding (losing) +11.18% (-0.12%) based on the difference between the final offering price and Friday’s close. What has been the country’s largest IPO, Thai’s retailer Central Retail (CRC TB: -1.79%) debuted poorly amid uncertainty over retail sales due to COVID-19, while E&P spin-off BW Energy (BWE NO: -0.12%) closed below its final offering price on the week and Brazilian construction engineering firm Priner (PRNR3 BZ: +49.30%) recorded big initial strength. Coming this week, Airtel Africa is set to spin off Airtel Malawi on the local exchange, PE-backed eyewear frames maker Inspecs (SPEC LN) joins the post-Brexit pipeline and Preclinical genetic medicine firm Passage Bio (PASG US) is added to the long list of “hot” biotech IPOs in the U.S. Other IPO News include: 1) Brazil state bank Caixa readies for its insurance unit IPO Caixa Seguridade; 2) more Brazilian upcoming IPOs include Carlyle-backed education unicorn Uniasselvi, shopping mall Almeida Junior and truck fleet BBM Logistica; 3) Investec confirms to spin off asset management unit Ninety One in mid-March; 4) Fortive’s industrial tech unit Vontier and Pfizer-backed biopharma startup IMARA joins U.S. pipeline.
**Terms applies

Track Priced & Upcoming IPOs on https://ipox.com/ipox-deals/

Lime Brokerage LLC is not affiliated with these service providers. Data, information, and material (“content”) is provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance. Lime Brokerage LLC does not endorse, offer or recommend any of the services nor information provided by any of the above service providers and any service or information used to execute any trading strategies are solely based on the independent analysis of the user.

You may also be interested in...

On Ups And Downs In Volatile Markets
Read More
The IPOX® Week, March 23, 2020
Read More
Putting Last Week’s Historic Volatility Into Perspective
Read More
The IPOX® Week, March 16, 2020
Read More

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.

OK